These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 30551382

  • 1. AOS ameliorates monocrotaline-induced pulmonary hypertension by restraining the activation of P-selectin/p38MAPK/NF-κB pathway in rats.
    Hu Y, Feng Z, Feng W, Hu T, Guan H, Mao Y.
    Biomed Pharmacother; 2019 Jan; 109():1319-1326. PubMed ID: 30551382
    [Abstract] [Full Text] [Related]

  • 2. [Effect of acidic oligosaccharides on P-selectin of pulmonary hypertensive rats induced by monocrotaline].
    Feng Z, Hu Y, An NN, Feng WJ, Hu T, Mao YJ.
    Zhonghua Jie He He Hu Xi Za Zhi; 2018 Feb 12; 41(2):90-94. PubMed ID: 29429213
    [Abstract] [Full Text] [Related]

  • 3. Thymoquinone attenuates monocrotaline-induced pulmonary artery hypertension via inhibiting pulmonary arterial remodeling in rats.
    Zhu N, Zhao X, Xiang Y, Ye S, Huang J, Hu W, Lv L, Zeng C.
    Int J Cardiol; 2016 Oct 15; 221():587-96. PubMed ID: 27420584
    [Abstract] [Full Text] [Related]

  • 4. Pathophysiological roles of nuclear factor kappaB (NF-kB) in pulmonary arterial hypertension: effects of synthetic selective NF-kB inhibitor IMD-0354.
    Hosokawa S, Haraguchi G, Sasaki A, Arai H, Muto S, Itai A, Doi S, Mizutani S, Isobe M.
    Cardiovasc Res; 2013 Jul 01; 99(1):35-43. PubMed ID: 23631839
    [Abstract] [Full Text] [Related]

  • 5. Activation of AMPK prevents monocrotaline-induced pulmonary arterial hypertension by suppression of NF-κB-mediated autophagy activation.
    Zhai C, Shi W, Feng W, Zhu Y, Wang J, Li S, Yan X, Wang Q, Zhang Q, Chai L, Li C, Liu P, Li M.
    Life Sci; 2018 Sep 01; 208():87-95. PubMed ID: 30009823
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of nuclear factor-κB in the lungs prevents monocrotaline-induced pulmonary hypertension in mice.
    Li L, Wei C, Kim IK, Janssen-Heininger Y, Gupta S.
    Hypertension; 2014 Jun 01; 63(6):1260-9. PubMed ID: 24614212
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Amlodipine prevents monocrotaline-induced pulmonary arterial hypertension and prolongs survival in rats independent of blood pressure lowering.
    Mawatari E, Hongo M, Sakai A, Terasawa F, Takahashi M, Yazaki Y, Kinoshita O, Ikeda U.
    Clin Exp Pharmacol Physiol; 2007 Jul 01; 34(7):594-600. PubMed ID: 17581214
    [Abstract] [Full Text] [Related]

  • 12. Baicalein attenuates monocrotaline-induced pulmonary arterial hypertension by inhibiting vascular remodeling in rats.
    Shi R, Wei Z, Zhu D, Fu N, Wang C, Yin S, Liang Y, Xing J, Wang X, Wang Y.
    Pulm Pharmacol Ther; 2018 Feb 01; 48():124-135. PubMed ID: 29133079
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Fluoxetine protects against monocrotaline-induced pulmonary arterial remodeling by inhibition of hypoxia-inducible factor-1α and vascular endothelial growth factor.
    Han DD, Wang Y, Zhang XH, Liu JR, Wang HL.
    Can J Physiol Pharmacol; 2012 Apr 01; 90(4):445-54. PubMed ID: 22448962
    [Abstract] [Full Text] [Related]

  • 15. 5-Aminosalicylic Acid Attenuates Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats by Increasing the Expression of Nur77.
    Sun LY, Cai ZY, Pu J, Li J, Shen JY, Yang CD, He B.
    Inflammation; 2017 Jun 01; 40(3):806-817. PubMed ID: 28213866
    [Abstract] [Full Text] [Related]

  • 16. Resveratrol inhibits monocrotaline-induced pulmonary arterial remodeling by suppression of SphK1-mediated NF-κB activation.
    Shi W, Zhai C, Feng W, Wang J, Zhu Y, Li S, Wang Q, Zhang Q, Yan X, Chai L, Liu P, Chen Y, Li M.
    Life Sci; 2018 Oct 01; 210():140-149. PubMed ID: 30179628
    [Abstract] [Full Text] [Related]

  • 17. A nuclear factor-kappaB inhibitor pyrrolidine dithiocarbamate ameliorates pulmonary hypertension in rats.
    Sawada H, Mitani Y, Maruyama J, Jiang BH, Ikeyama Y, Dida FA, Yamamoto H, Imanaka-Yoshida K, Shimpo H, Mizoguchi A, Maruyama K, Komada Y.
    Chest; 2007 Oct 01; 132(4):1265-74. PubMed ID: 17934115
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. H2S inhibits pulmonary arterial endothelial cell inflammation in rats with monocrotaline-induced pulmonary hypertension.
    Feng S, Chen S, Yu W, Zhang D, Zhang C, Tang C, Du J, Jin H.
    Lab Invest; 2017 Mar 01; 97(3):268-278. PubMed ID: 27941756
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.